marginally significantp < 0.13
This NEU-treated increase in F ECL+IgG was statistically significant (p < 0.08) for Octagam, 4G8a, and 4G8b and marginally significant for Gammagard (0.11 < p < 0.13).
This NEU-treated increase in F ECL+IgG was statistically significant (p < 0.08) for Octagam, 4G8a, and 4G8b and marginally significant for Gammagard (0.11 < p < 0.13).